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Background: Adhesion formation after abdominal surgery (especially multiple operations) is still a major
cause of morbidities such as infertility, pain, bowel obstruction, difﬁcult reoperation and other compli-
cations. Our aim was to investigate the ability of rat amniotic ﬂuid to prevent adhesion formation after
laparatomy in rats.
Methods: This experimental trial was conducted in 20 pregnant rats randomly assigned to two groups of
10 animals each. Measurable serosal and intestinal injuries were created with a standard technique. Rats
in both groups underwent laparatomy and hysterectomy. Then amniotic ﬂuid was poured into the
abdominal cavity of animals in the case group. All animals were operated on 4 weeks after initial surgery
to assess adhesions, which were scored by an examiner who was blind to the animals’ group assignment.
Results: The frequency of severe adhesions was 30% in the control group and 0% in the intervention
group. Total adhesion scores were signiﬁcantly lower in the amniotic ﬂuid treatment group than in the
control group (P ¼ 0.002).
Conclusions: Rat amniotic ﬂuid can decrease the likelihood of post-operative intraperitoneal adhesion
formation.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Adhesion formation, the joiningof twonormallyseparate surfaces,
causes major complications and morbidities after surgical proce-
dures.1 It can cause severe morbidities such as infertility, pain, bowel
obstruction and subsequent intra-operative complications.2,3 Adhe-
sions also affect surgical outcomes because they can cause intra- and
post-operative morbidities and decrease fertility inwomen.4
Peritoneal adhesions are ﬁbrous bands between organs that are
normally separated, or between organs and other areas such as
internal body surfaces. Many intra-abdominal adhesions are the
result of trauma or injury caused by a surgical procedure or intra-
abdominal sepsis. Cadaver studies showed adhesions in 67% of
patients with prior procedures and in 28% with a previous intra-
abdominal infection. Abdominal adhesions are the most common
cause of bowel obstruction (65%e75%), and lower abdominal
procedures have a higher chance of producing adhesion and
obstruction.5 Thus, preventing adhesion formation is one of the: þ98 711 2330724.
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ciates Ltd. Published by Elsevier Ltmost important concerns of all surgeons.6 In our experience with
different surgical procedures we have observed that inwomenwho
undergo a second operation after a previous cesarean delivery, the
degree of adhesion formation is signiﬁcantly decreased or even
absent. This led us to hypothesize that the amniotic ﬂuid that
bathes the abdominal cavity during cesarean delivery may be
responsible for reducing adhesion formation.
Factors such as hyaluronic acid and growth factor may be
responsible, through different mechanisms, for the ability of
amniotic ﬂuid to prevent and treat adhesion formation. One
mechanism may be by acting as a mechanical barrier between two
injured peritoneal surfaces.7,8 In the present studywe evaluated the
efﬁcacy of rat amniotic ﬂuid in preventing adhesion formation in an
animal model.
2. Methods
The study was an experimental randomized controlled animal trial. A total of 20
pregnant female (gestational age 14  2 days) Wistar-Albino rats weighting
250e300 g (mean 275 g) were randomly assigned to two groups of 10 animals each
in accordance with the guidelines of the Animal Ethics Committee of Shiraz
University of Medical Sciences. All surgical procedures were performed by the same
surgeon. Each rat was anesthetized with ketamin hydrochloride (50mg/kg i.m.), and
before the incision, the abdomen was shaved and prepared with povidine iodine
solution with a sterile technique. The abdominal cavity was opened via a 4-cm
vertical midline incision. First hysterectomywas done and thenmultiple measurabled. All rights reserved.
Table 1
Adhesion scoring system according to Canbaz and colleagues.9
Degree
of adhesion
Number of adhesion bands
0 No adhesion
1 One adhesion band, no vessel, easily separated
2 Two thin adhesion bands, no vessel, easily separated
3 Three thin adhesion bands, no vessel, easily separated
4 More than three thin adhesion bands, easily separated
with no vessel or diffuse adhesion bands with vessels
S. Tahmasebi et al. / International Journal of Surgery 10 (2012) 16e19 17
ORIGINAL RESEARCHabrasions were made on the different site of peritoneal surface and small intestine
by nife. Care was taken to avoid gross bleeding from the injured sites. In the study
group about 3e4 mL of the amniotic ﬂuid from each rat was poured in to the
abdominal cavity. Then the abdominal cavity in both groups was closed in a double
layer with continuous suturing (muscle and peritoneum with 4-0 chromic suture,
fascia and skin with 4-0 nylon suture). After that the rats were housed under
controlled temperature conditions (21 2 C) and a 12/12 light/dark cycle with food
and water available. After 4 weeks the animals were killed by KCl injection to
evaluate adhesion formation.
The extent and severity of adhesions at the incision site, between bowel loops
and between bowel loops and the peritoneal surface were evaluated with an
established scoring systemwhich it explain in Table 1.This scoring system utilized in
different article for scoring of adhesion band. The investigator (surgery resident)
who scored the adhesions had no knowledge of the animals’ group assignment. The
signiﬁcance of the difference between the two groups was calculated with the
ManneWhitney U test Figs 1 and 2.
3. Results
All rats recovered and resumed their preoperative health and
activities after surgery. No residual viscous or ascites ﬂuid was
observed in the abdominal cavity. The number of adhesions, their
severity and total adhesion scores are shown in Table 2. In the
intervention group, entry to the abdominal cavity wasFig. 1. Adhesions of bowel loops to each other and to other organs in the control group. A. A
the site of incision (INC). C. Adhesion bands between bowel loops and the abdominal wallstraightforward because there were no adhesions around the lapa-
rotomy incision. No score-4 adhesions were found between the
bowel loops.
The statistical analysis showed signiﬁcant differences between
the two groups (ManneWhitney U ¼ 11, asymptomatic
signiﬁcance ¼ 0.002, exact signiﬁcance ¼ 0.002, P ¼ 0.001).
Signiﬁcantly fewer and signiﬁcantly less severe adhesions were
found in the intervention group.4. Discussion
We tested the ability of rat amniotic ﬂuid to inhibit the forma-
tion of peritoneal cavity adhesions, and found that the prevalence
of adhesions and their severity were signiﬁcantly lower in the
intervention group than in the control group (P ¼ 0.002). Post-
operative adhesion formation has a considerable effect on quality of
life and health. One of the greatest problems of gynecological and
abdominal surgery is pelvic adhesions, and their prevention is of
great concern to all surgeons. Different types of adhesion-reducing
substances have been used in animal models but we are still far
from the ideal substance.10
Somematerials suchashyaluronicacidhaveyieldedgoodresults in
reducing intrauterine adhesion formation.11 Unfortunately, many of
these agents are expensive and not readily available. An important
factor inadhesion formation is collagendeposition, andmaterials such
as d-penicillamine favor the prevention of adhesion band formation.
This drug keeps the ﬁbers loose and unstable so that they cannot
perform their binding role in the absence of collagen ﬁber cross-
linking.11
Physical barriers are another effective method of preventing
adhesions. A randomized clinical trial involving11 centers in theUSAdhesion bands (AB) between bowel loops. B. Adhesion bands between bowel loops and
(AW).
Fig. 2. No adhesions of bowel loops to each other, to the abdominal wall or to the site
of incision in the intervention group.
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Corporation, Cambridge, MA) was effective in decreasing adhesions
only at the site of application.12 However, its efﬁcacy in reducing
adhesions in areas other than the site of use is unclear.13 Therefore
a physical barrier used in a limited area may not completely elimi-
nate adhesion formation. In contrast, systemic drugs can reduce
adhesions throughout the abdomen cavity and are therefore likely
to be more effective than purely physical barriers.11
We use a safe, natural material to prevent adhesion formation,
but at this time we can offer no explanation for its mechanism of
action. One hypothetical mechanism is that amniotic ﬂuid acts as
a mechanical barrier between injured peritoneal surfaces.14 Its
healing characteristics may also be effective; for example, the
amniotic ﬂuid environment may act in scar-healing in the fetus.7
This ﬂuid contains many factors such as hyaluronic acid(HA) and
growth factor whichmay be responsible for this characteristic.8 HA is
glycosaminoglycan and a component of the Extracellular matrix,
including connective tissue, cartilage, skin, vitreous and synovial
ﬂuids.HA isbiocompatible, nonimmunogenic, nontoxic, and soluble.17
HA cover serosal surfaces and causes protection of serosal
surface.18 Because of the high content of HA in fetal wounds, it
reduces collagen deposition and therefore lead to less scar forma-
tion.19 This suggestion is similar to the research of West et al., who
showed removal of HA results in ﬁbrosis and scar formation.20
One of the mechanism of HA is decreasing the activity and
proliferation of ﬁbroblasts, and prevention of ﬁbrin deposition on
the injured serosal surfaces, and ﬁnally inhibit migration of
inﬂammatory cells and cellular elements during repair.21
In orthopedic surgery human amniotic ﬂuid is used immediately
after tenorrhaphy to successfully prevent peri-tendinous adhesion
formation in a rabbit model.15 Bovine amniotic ﬂuid may also be
efﬁcacious in burns.16
Another question we cannot answer at present is which compo-
nent or components of amnioticﬂuid reduce the strength or number
of the adhesion bands. Longer follow-up and further histological
evaluations of tissue samples are required to answer these questions.Table 2
Severity and total scores for severity of adhesions in rats subjected to surgery with
(Case) and without (Control) intraperitoneal lavage with amniotic ﬂuid.
Degree 0 1 2 3 4
Control 1 3 3 1 2
Case 7 3 0 0 0In comparison to synthetic drugs, amniotic ﬂuid has no side
effects. In addition, no sign of evisceration or dehiscence were
found after the use of amniotic ﬂuid. We therefore suggest that if
amniotic ﬂuid is used to prevent adhesions in humans, it could be
collected at birth and deposited in amniotic ﬂuid banks for use in
surgery. Another suggestion is to analyze amniotic ﬂuid to identify
the component or components that effectively inhibit adhesion
band formation. These components could then be used as safe
materials to prevent adhesions.
Wewere unable toﬁnd any published studies that evaluated the
use of rat amniotic ﬂuid to prevent adhesions. Our review of the
literature from 1972 till now using different keywords returned no
articles on amniotic ﬂuid and adhesion formation similar to our
study. In otherwords, the potential uses of amniotic ﬂuid in surgery
have not been studied widely, and this made it difﬁcult to compare
our results with those of other studies. Our study in a rat model of
postsurgical adhesion formation and prevention approaches
adhesion prevention from a new perspective that aims to test
whether the animal’s own amniotic ﬂuid can decreases the rate and
severity of post-operative adhesions.
In conclusion, this experimental study investigated the
prevention of post-operative adhesion formation by rat amniotic
ﬂuid. Additional studies will be needed to ascertain whether
amniotic ﬂuid is effective in long-term adhesion reformation.
Finding an effective agent to decrease adhesion formation would
improve the post-operative course for surgical procedures with
a high risk of adhesion formation.
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